Decoding the Genetic Landscape of Skeletal Diseases
Launched by KAROLINSKA INSTITUTET · May 16, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Decoding the Genetic Landscape of Skeletal Diseases," is focused on finding the genetic causes of certain skeletal disorders that have not been explained by current medical knowledge. Over the next five years, researchers will use advanced techniques to analyze the genetic information of patients who have congenital skeletal disorders, also known as genetic skeletal diseases (GSDs). They will study how these genetic changes affect cells and specially designed mice, and they will gather information about the natural progression and possible complications of different types of GSDs.
If you or a family member has been diagnosed with a skeletal dysplasia—meaning there are abnormalities with the bones or growth—this study may be a good fit. Eligible participants include those with unusual height, abnormal bone structures seen on X-rays, and other related features, as well as healthy relatives of affected individuals. Participants can expect to undergo genetic testing and contribute to research that may lead to a better understanding of these disorders. This trial is currently recruiting individuals of all ages and genders, and it's an opportunity to help advance knowledge in this important area of medicine.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinically suspected skeletal dysplasia based on previous investigations
- • Abnormal height
- • Radiographic abnormalities of the skeleton in addition to other syndromic features
- • Healthy relatives of the affected study participants
- Exclusion Criteria:
- • No radiographic data available from clinical investigations
- • Suspected environmental or multifactorial causes
About Karolinska Institutet
Karolinska Institutet is a renowned medical university located in Sweden, recognized for its commitment to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the institution focuses on translating scientific discoveries into effective treatments and therapies, emphasizing patient-centered approaches. With a strong emphasis on collaboration and interdisciplinary research, Karolinska Institutet plays a pivotal role in addressing global health challenges and improving patient outcomes, leveraging its extensive network of experts and state-of-the-art facilities to drive clinical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Stockholm, , Sweden
Patients applied
Trial Officials
Giedre Grigelioniene, MD,
Principal Investigator
Dept Molecular Medicine and Surgery, KI
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported